United States Brucellosis Vaccines Market Report 2016

Publisher Name :
Date: 13-Sep-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Brucellosis Vaccines

Revenue, means the sales value of Brucellosis Vaccines

This report studies sales (consumption) of Brucellosis Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer HealthCare AG (Germany)

- Biogenesis-Bago (Argentina)

- Boehringer Ingelheim GmbH (Germany)

- Ceva Sante Animale (France)

- Heska Corporation (US)

- Indian Immunologicals Ltd (India)

- Lohmann Animal Health (US)

- Merck Animal Health (US)

- Merial Ltd. (US)

- Protein Sciences Corporation (US)

- Virbac SA (France)

- Zoetis Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Brucellosis Vaccines in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Brucellosis Vaccines Market Report 2016

Table of Contents
United States Brucellosis Vaccines Market Report 2016
1 Brucellosis Vaccines Overview
1.1 Product Overview and Scope of Brucellosis Vaccines
1.2 Classification of Brucellosis Vaccines
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Brucellosis Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Brucellosis Vaccines (2011-2021)
1.4.1 USA Brucellosis Vaccines Sales and Growth Rate (2011-2021)
1.4.2 USA Brucellosis Vaccines Revenue and Growth Rate (2011-2021)
2 USA Brucellosis Vaccines Competition by Manufacturers
2.1 USA Brucellosis Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Brucellosis Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Brucellosis Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Brucellosis Vaccines Market Competitive Situation and Trends
2.4.1 Brucellosis Vaccines Market Concentration Rate
2.4.2 Brucellosis Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Brucellosis Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Brucellosis Vaccines Sales and Market Share by Type (2011-2016)
3.2 USA Brucellosis Vaccines Revenue and Market Share by Type (2011-2016)
3.3 USA Brucellosis Vaccines Price by Type (2011-2016)
3.4 USA Brucellosis Vaccines Sales Growth Rate by Type (2011-2016)
4 USA Brucellosis Vaccines Sales (Volume) by Application (2011-2016)
4.1 USA Brucellosis Vaccines Sales and Market Share by Application (2011-2016)
4.2 USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Brucellosis Vaccines Manufacturers Profiles/Analysis
5.1 Bayer HealthCare AG (Germany)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Brucellosis Vaccines Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Biogenesis-Bago (Argentina)
5.2.2 Brucellosis Vaccines Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Boehringer Ingelheim GmbH (Germany)
5.3.2 Brucellosis Vaccines Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Ceva Sante Animale (France)
5.4.2 Brucellosis Vaccines Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Ceva Sante Animale (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Heska Corporation (US)
5.5.2 Brucellosis Vaccines Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Heska Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Indian Immunologicals Ltd (India)
5.6.2 Brucellosis Vaccines Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Lohmann Animal Health (US)
5.7.2 Brucellosis Vaccines Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Lohmann Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Merck Animal Health (US)
5.8.2 Brucellosis Vaccines Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Merck Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Merial Ltd. (US)
5.9.2 Brucellosis Vaccines Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Merial Ltd. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Protein Sciences Corporation (US)
5.10.2 Brucellosis Vaccines Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Protein Sciences Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Virbac SA (France)
5.12 Zoetis Inc. (US)
6 Brucellosis Vaccines Manufacturing Cost Analysis
6.1 Brucellosis Vaccines Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Brucellosis Vaccines
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Brucellosis Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Brucellosis Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Brucellosis Vaccines Market Forecast (2016-2021)
10.1 USA Brucellosis Vaccines Sales, Revenue Forecast (2016-2021)
10.2 USA Brucellosis Vaccines Sales Forecast by Type (2016-2021)
10.3 USA Brucellosis Vaccines Sales Forecast by Application (2016-2021)
10.4 Brucellosis Vaccines Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Brucellosis Vaccines
Table Classification of Brucellosis Vaccines
Figure USA Sales Market Share of Brucellosis Vaccines by Type in 2015
Table Application of Brucellosis Vaccines
Figure USA Sales Market Share of Brucellosis Vaccines by Application in 2015
Figure USA Brucellosis Vaccines Sales and Growth Rate (2011-2021)
Figure USA Brucellosis Vaccines Revenue and Growth Rate (2011-2021)
Table USA Brucellosis Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Brucellosis Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Brucellosis Vaccines Sales Share by Manufacturers
Figure 2016 Brucellosis Vaccines Sales Share by Manufacturers
Table USA Brucellosis Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Brucellosis Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Brucellosis Vaccines Revenue Share by Manufacturers
Table 2016 USA Brucellosis Vaccines Revenue Share by Manufacturers
Table USA Market Brucellosis Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Brucellosis Vaccines Average Price of Key Manufacturers in 2015
Figure Brucellosis Vaccines Market Share of Top 3 Manufacturers
Figure Brucellosis Vaccines Market Share of Top 5 Manufacturers
Table USA Brucellosis Vaccines Sales by Type (2011-2016)
Table USA Brucellosis Vaccines Sales Share by Type (2011-2016)
Figure USA Brucellosis Vaccines Sales Market Share by Type in 2015
Table USA Brucellosis Vaccines Revenue and Market Share by Type (2011-2016)
Table USA Brucellosis Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Brucellosis Vaccines by Type (2011-2016)
Table USA Brucellosis Vaccines Price by Type (2011-2016)
Figure USA Brucellosis Vaccines Sales Growth Rate by Type (2011-2016)
Table USA Brucellosis Vaccines Sales by Application (2011-2016)
Table USA Brucellosis Vaccines Sales Market Share by Application (2011-2016)
Figure USA Brucellosis Vaccines Sales Market Share by Application in 2015
Table USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Brucellosis Vaccines Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Brucellosis Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Brucellosis Vaccines
Figure Manufacturing Process Analysis of Brucellosis Vaccines
Figure Brucellosis Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Brucellosis Vaccines Major Manufacturers in 2015
Table Major Buyers of Brucellosis Vaccines
Table Distributors/Traders List
Figure USA Brucellosis Vaccines Production and Growth Rate Forecast (2016-2021)
Figure USA Brucellosis Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table USA Brucellosis Vaccines Production Forecast by Type (2016-2021)
Table USA Brucellosis Vaccines Consumption Forecast by Application (2016-2021)
  • Global Vegetable Capsules Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 22-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Vegetarian capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Vegetarian capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and HPMC (Hydroxyl Propyl Methyl Celluloses). Vegetarian capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; E......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Vegetable Capsules Market 2018, Forecast to 2023
    Published: 22-Jun-2018        Price: US 4880 Onwards        Pages: 131
    Vegetarian capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Vegetarian capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and HPMC (Hydroxyl Propyl Methyl Celluloses). Vegetarian capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; E......
  • Global Sugar Sphere Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 22-Jun-2018        Price: US 3480 Onwards        Pages: 131
    Sugar spheres are a widely used excipient for sustained-release pellet formulations. Sugar spheres (also called neutral pellets, nonpareil seeds, microgranules or sugar beads) are produced, preferably using a layered sugar-coating structure. The result is sugar spheres with sufficient mechanical stability for further processing. Scope of the Report: This report focuses on the Sugar Sphere in global market, especially in North America, Europe and Asia-Pacific, South America,......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Sugar Sphere Market 2018, Forecast to 2023
    Published: 22-Jun-2018        Price: US 4880 Onwards        Pages: 132
    Sugar spheres are a widely used excipient for sustained-release pellet formulations. Sugar spheres (also called neutral pellets, nonpareil seeds, microgranules or sugar beads) are produced, preferably using a layered sugar-coating structure. The result is sugar spheres with sufficient mechanical stability for further processing. Scope of the Report: This report focuses on the Sugar Sphere in global market, especially in North America, Europe and Asia-Pacific, South America,......
  • Global Androstenedione Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Jun-2018        Price: US 3480 Onwards        Pages: 152
    Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) - an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone. Scope of the Report: This report focuses on the Androstenedione in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Androstenedione is used to evaluate the function of t......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Androstenedione Market 2018, Forecast to 2023
    Published: 21-Jun-2018        Price: US 4880 Onwards        Pages: 148
    Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) - an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone. Scope of the Report: This report focuses on the Androstenedione in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Androstenedione is used to evaluate the function of t......
  • Global Soft Gelatin Capsules Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Jun-2018        Price: US 3480 Onwards        Pages: 152
    Soft Gelatin Capsules are a type of capsules with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Scope of the Report: This report focuses on the Soft Gelatin Capsules in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and ap......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Soft Gelatin Capsules Market 2018, Forecast to 2023
    Published: 21-Jun-2018        Price: US 4880 Onwards        Pages: 150
    Soft Gelatin Capsules are a type of capsules with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Scope of the Report: This report focuses on the Soft Gelatin Capsules in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and ap......
  • Global Keyhole Limpet Hemocyanin (KLH) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 129
    KLH, which can be used as an active pharmaceutical ingredient ("API"), is a very large, high molecular weight, oxygen-carrying glycoprotein made of millions of atoms. There are two KLH subunit forms, KLH1 and KLH2, each composed of seven or eight functional units, with each functional unit having an oxygen binding site of two copper atoms. Keyhole limpet hemocyanin is an extremely large, heterogeneous glycosylated protein consisting of subunits with a molecular weight of 350,000 and 390,000 in a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs